IL296955A - Method for editing target rna - Google Patents

Method for editing target rna

Info

Publication number
IL296955A
IL296955A IL296955A IL29695522A IL296955A IL 296955 A IL296955 A IL 296955A IL 296955 A IL296955 A IL 296955A IL 29695522 A IL29695522 A IL 29695522A IL 296955 A IL296955 A IL 296955A
Authority
IL
Israel
Prior art keywords
dyw
sequence
editing
rna
seq
Prior art date
Application number
IL296955A
Other languages
English (en)
Hebrew (he)
Original Assignee
Editforce Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Editforce Inc filed Critical Editforce Inc
Publication of IL296955A publication Critical patent/IL296955A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL296955A 2020-03-31 2021-03-31 Method for editing target rna IL296955A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020065065 2020-03-31
PCT/JP2021/014096 WO2021201198A1 (ja) 2020-03-31 2021-03-31 標的rnaを編集する方法

Publications (1)

Publication Number Publication Date
IL296955A true IL296955A (en) 2022-12-01

Family

ID=77930108

Family Applications (1)

Application Number Title Priority Date Filing Date
IL296955A IL296955A (en) 2020-03-31 2021-03-31 Method for editing target rna

Country Status (11)

Country Link
US (1) US20230125942A1 (cg-RX-API-DMAC7.html)
EP (1) EP4130274A4 (cg-RX-API-DMAC7.html)
JP (4) JP7668547B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220165747A (cg-RX-API-DMAC7.html)
CN (1) CN115698296A (cg-RX-API-DMAC7.html)
AU (1) AU2021248204A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022019571A2 (cg-RX-API-DMAC7.html)
CA (1) CA3179365A1 (cg-RX-API-DMAC7.html)
IL (1) IL296955A (cg-RX-API-DMAC7.html)
TW (2) TW202615452A (cg-RX-API-DMAC7.html)
WO (1) WO2021201198A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250281571A1 (en) * 2021-04-30 2025-09-11 Osaka University Therapeutic drug for myotonic dystrophy type 1
WO2023120658A1 (ja) * 2021-12-24 2023-06-29 国立大学法人北陸先端科学技術大学院大学 酵素、複合体、組換えベクター、遺伝性疾患治療薬及びポリヌクレオチド
WO2024249445A2 (en) * 2023-05-26 2024-12-05 The Trustees Of Columbia University In The City Of New York An rna recognition and editing code of pentatricopeptide repeat proteins
CN117384884B (zh) * 2023-11-30 2024-03-08 辉大(上海)生物科技有限公司 IscB多肽及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911501A2 (pt) * 2008-04-29 2015-07-28 Monsanto Technology Llc Genes e usos para melhoramento de plantas.
ES2751126T3 (es) * 2011-10-21 2020-03-30 Univ Kyushu Nat Univ Corp Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo
KR20160007541A (ko) 2013-04-22 2016-01-20 고쿠리쓰다이가쿠호진 규슈다이가쿠 피피알 모티프를 이용한 디앤에이 결합성 단백질 및 그의 이용

Also Published As

Publication number Publication date
EP4130274A1 (en) 2023-02-08
JP7698351B2 (ja) 2025-06-25
CN115698296A (zh) 2023-02-03
JPWO2021201198A1 (cg-RX-API-DMAC7.html) 2021-10-07
EP4130274A4 (en) 2024-05-22
JP2025120313A (ja) 2025-08-15
US20230125942A1 (en) 2023-04-27
JP7897387B2 (ja) 2026-07-29
JP7668547B2 (ja) 2025-04-25
AU2021248204A1 (en) 2022-11-10
TW202615452A (zh) 2026-04-16
WO2021201198A1 (ja) 2021-10-07
TWI899197B (zh) 2025-10-01
JP2024096897A (ja) 2024-07-17
KR20220165747A (ko) 2022-12-15
JP7698371B1 (ja) 2025-06-25
CA3179365A1 (en) 2021-10-07
BR112022019571A2 (pt) 2022-12-06
TW202204382A (zh) 2022-02-01
JP2025107239A (ja) 2025-07-17

Similar Documents

Publication Publication Date Title
Bürmann et al. Cryo-EM structure of MukBEF reveals DNA loop entrapment at chromosomal unloading sites
IL275244A (en) Use of programmable DNA-binding proteins to enhance intended genome modification
Mukai et al. Highly reproductive Escherichia coli cells with no specific assignment to the UAG codon
EP4022053A1 (en) C-to-g transversion dna base editors
IL257178A (en) Genome modification is based on crispr
JP6487306B2 (ja) Pprモチーフを利用したdna結合性タンパク質およびその利用
IL296057A (en) Ribonucleic acid-guided genome recombination engineering at the scale of thousands of bases
WO2019185751A1 (en) Inhibitors of crispr-cas associated activity
CA3179365A1 (en) Method for editing target rna
Ender et al. Evidence for autocatalytic cross-linking of hydroxyproline-rich glycoproteins during extracellular matrix assembly in Volvox
JP7749763B2 (ja) 凝集の少ないpprタンパク質及びその利用
Gutiérrez-García et al. Structural and functional analysis of tomato sterol C22 desaturase
Francis et al. Site-directed mutagenesis and its application in studying the interactions of T3S components
IL294120B2 (en) High fidelity spcas9 nucleases for genome modification
Ma et al. Discovery and identification of a novel tag of HlyA60 for protein active aggregate formation in Escherichia coli
IL286917B (en) Methods for scar-free insertion of targeted modifications into targeted vectors
Vijayakumar Controlled Design and Production of Tunable Modular Protein Nanoparticles
IL322759A (en) Animal proteins in cyanobacteria
HK40070059A (en) Ppr protein with less aggregation and use thereof
Baglieri Assembly and mechanism of bacterial twin-arginine translocation systems
CN120081906A (zh) 一种α-螺旋束结构多肽及其在治疗阿尔兹海默症中的应用
Chaijarasphong Towards an in Vitro Reconstitution of the α-Carboxysome
IL313682A (en) Artificial dna molecules, cells, transgenic plants, and use of same for preparing milk-like micelles
Drahos et al. Protein Expression and Folding Optimization for High-Throughput Proteomics
Pal INVESTIGATION OF THE POTENTIAL INTERACTIVE COMPONENTS OF cpTAT PATHWAY WITH THE PRECURSOR DURING TRANSPORT